Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
Goldspiel
B R
BR
Kohler
D R
DR
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use*; D017294:Ondansetron / Q000627:therapeutic use*; D012107:Research Design; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control*
D017294:Ondansetron; D016190:Carboplatin; D008787:Metoclopramide; D002945:Cisplatin